|
Neutropenia Global Clinical Trials Review, H1, 2012
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 105 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData's clinical trial report, “Neutropenia Global Clinical Trials Review, H1, 2012" provides data on the Neutropenia clinical trial scenario. This report provides elemental informa.....
Introduction GlobalData's clinical trial report, “Neutropenia Global Clinical Trials Review, H1, 2012" provides data on the Neutropenia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neutropenia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Neutropenia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Highlights Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies [Studien Infos ausblenden] |
|||||||||||
|
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 6 Introduction 7 Neutropenia 7 Report Guidance 7 Clinical Trials by Region 8 Clinical Trials by Country 9 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11 Top Five Countries Contributing to Clinical Trials in Europe 12 Top Countries Contributing to Clinical Trials in North America 13 Top Countries Contributing to Clinical Trials in Middle East and Africa 14 Top Five Countries Contributing to Clinical Trials in Central and South America 15 Clinical Trials by BRIC Nations 16 Clinical Trials by G7 Nations 17 Clinical Trials in G7 Nations by Trial Status 18 Clinical Trials by E7 Nations 19 Clinical Trials in E7 Nations by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Unaccomplished Trials of Neutropenia 24 Subjects Recruited Over a Period of Time 26 Prominent Sponsors 27 Top Companies Participating in Neutropenia Therapeutics Clinical Trials 29 Prominent Drug Comparison 31 Clinical Trial Profiles 32 Clinical Trial Overview of Top Companies 32 Pfizer Inc. 32 Clinical Trial Overview of Pfizer Inc. 32 Amgen Inc. 33 Clinical Trial Overview of Amgen Inc. 33 Merck & Co., Inc. 34 Clinical Trial Overview of Merck & Co., Inc. 34 Johnson & Johnson 35 Clinical Trial Overview of Johnson & Johnson 35 Sandoz Inc. 36 Clinical Trial Overview of Sandoz Inc. 36 Enzon Pharmaceuticals, Inc. 37 Clinical Trial Overview of Enzon Pharmaceuticals, Inc. 37 Gennova Biopharmaceuticals 38 Clinical Trial Overview of Gennova Biopharmaceuticals 38 Eurofarma 39 Clinical Trial Overview of Eurofarma 39 Synageva BioPharma Corp. 40 Clinical Trial Overview of Synageva BioPharma Corp. 40 Sanquin Pharmaceutical Services 41 Clinical Trial Overview of Sanquin Pharmaceutical Services 41 Shantha Biotechnics Limited 42 Clinical Trial Overview of Shantha Biotechnics Limited 42 Telik, Inc. 43 Clinical Trial Overview of Telik, Inc. 43 Teva Pharmaceutical Industries Limited 44 Clinical Trial Overview of Teva Pharmaceutical Industries Limited 44 Dr. Reddy's Laboratories Limited 45 Clinical Trial Overview of Dr. Reddy's Laboratories Limited 45 Dong-A Pharmaceutical Co., Ltd. 46 Clinical Trial Overview of Dong-A Pharmaceutical Co., Ltd. 46 Gilead Sciences, Inc. 47 Clinical Trial Overview of Gilead Sciences, Inc. 47 GlaxoSmithKline plc 48 Clinical Trial Overview of GlaxoSmithKline plc 48 Kyowa Hakko Kirin Co., Ltd. 49 Clinical Trial Overview of Kyowa Hakko Kirin Co., Ltd. 49 Clinical Trial Overview of Top Universities / Institutes / Hospitals 50 Memorial Sloan Kettering Cancer Center 50 Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 50 The National Institute of Allergy and Infectious Diseases 51 Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 51 The University of Texas M. D. Anderson Cancer Center 52 Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 52 Harvard School of Public Health 53 Clinical Trial Overview of Harvard School of Public Health 53 Assistance Publique - Hopitaux de Paris 54 Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 54 University of California, San Francisco 55 Clinical Trial Overview of University of California, San Francisco 55 Wake Forest University 56 Clinical Trial Overview of Wake Forest University 56 UCLA's Jonsson Comprehensive Cancer Center 57 Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center 57 European Organization for Research and Treatment of Cancer 58 Clinical Trial Overview of European Organization for Research and Treatment of Cancer 58 Centre Francois Baclesse 59 Clinical Trial Overview of Centre Francois Baclesse 59 University of Nebraska 60 Clinical Trial Overview of University of Nebraska 60 The Cleveland Clinic 61 Clinical Trial Overview of The Cleveland Clinic 61 Khon Kaen University 62 Clinical Trial Overview of Khon Kaen University 62 The Children's Hospital of Philadelphia 63 Clinical Trial Overview of The Children's Hospital of Philadelphia 63 Asan Medical Center 64 Clinical Trial Overview of Asan Medical Center 64 Seoul National University Hospital 65 Clinical Trial Overview of Seoul National University Hospital 65 Rabin Medical Center 66 Clinical Trial Overview of Rabin Medical Center 66 Cornell University 67 Clinical Trial Overview of Cornell University 67 Northwestern University 68 Clinical Trial Overview of Northwestern University 68 Rush University Medical Center 69 Clinical Trial Overview of Rush University Medical Center 69 Five Key Clinical Profiles 70 Appendix 102 Abbreviations 102 Definitions 102 Research Methodology 103 Secondary Research 104 About GlobalData 104 Contact Us 104 Disclaimer 104 Source 105 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
List of Tables Neutropenia Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8 Neutropenia Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9 Neutropenia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10 Neutropenia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11 Neutropenia Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12 Neutropenia Therapeutics Clinical Trials, North America, Top Countries, 2012* 13 Neutropenia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 14 Neutropenia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 15 Neutropenia Therapeutics Clinical Trials, BRIC Countries, 2012* 16 Neutropenia Therapeutics Clinical Trials, G7 Countries, 2012* 17 Neutropenia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18 Neutropenia Therapeutics Clinical Trials, E7 Countries, 2012* 19 Neutropenia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20 Neutropenia Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21 Neutropenia Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22 Neutropenia Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23 Neutropenia Therapeutics Market, Global, Suspended Clinical Trials, 2012* 24 Neutropenia Therapeutics Market, Global, Terminated Clinical Trials, 2012* 25 Neutropenia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 26 Neutropenia Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 28 Neutropenia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 30 Neutropenia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 31 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 32 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012* 33 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 34 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012* 35 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sandoz Inc., 2012* 36 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Enzon Pharmaceuticals, Inc., 2012* 37 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Gennova Biopharmaceuticals, 2012* 38 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eurofarma, 2012* 39 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Synageva BioPharma Corp., 2012* 40 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanquin Pharmaceutical Services, 2012* 41 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Shantha Biotechnics Limited, 2012* 42 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Telik, Inc., 2012* 43 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2012* 44 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Reddy's Laboratories Limited, 2012* 45 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Dong-A Pharmaceutical Co., Ltd., 2012* 46 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2012* 47 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 48 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyowa Hakko Kirin Co., Ltd., 2012* 49 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 50 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2012* 51 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 52 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Harvard School of Public Health, 2012* 53 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012* 54 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012* 55 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012* 56 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2012* 57 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2012* 58 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Francois Baclesse, 2012* 59 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2012* 60 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2012* 61 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Khon Kaen University, 2012* 62 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children's Hospital of Philadelphia, 2012* 63 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2012* 64 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2012* 65 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rabin Medical Center, 2012* 66 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cornell University, 2012* 67 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012* 68 Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rush University Medical Center, 2012* 69 List of Figures Neutropenia Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8 Neutropenia Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9 Neutropenia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10 Neutropenia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11 Neutropenia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12 Neutropenia Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13 Neutropenia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 14 Neutropenia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 15 Neutropenia Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16 Neutropenia Therapeutics Clinical Trials, G7 Countries (%), 2012* 17 Neutropenia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18 Neutropenia Therapeutics Clinical Trials, E7 Countries (%), 2012* 19 Neutropenia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20 Neutropenia Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21 Neutropenia Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22 Neutropenia Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23 Neutropenia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 26 Neutropenia Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 27 Neutropenia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 29 Neutropenia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 31 GlobalData Methodology 103 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
